首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Antibodies

缩写:

ISSN:N/A

e-ISSN:2073-4468

IF/分区:2.7/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引646
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Ming-Ching Hsieh,Chao Richard Li,Margaret A Velardo et al. Ming-Ching Hsieh et al.
Background: This study assesses the robustness of a legacy N-glycan profiling method for the therapeutic antibody MAB1 with different Peptide-N-glycosidase F (PNGase F) enzyme sources, solid phase extraction (SPE) cartrid...
Stoimen Dimitrov,Mihael Tsalta-Mladenov,Plamena Kabakchieva et al. Stoimen Dimitrov et al.
Paraneoplastic neurological syndromes (PNSs) are immune-mediated disorders caused by an antitumor response that cross-reacts with the nervous system, leading to severe and often irreversible neurological disability. Once considered exceedin...
Muhammad Soyfoo,Julie Sarrand Muhammad Soyfoo
Autoantibodies have long been regarded as passive reflections of immune dysregulation in connective tissue diseases (CTDs). Recent advances in systems immunology and molecular pathology have fundamentally redefined them as active molecular ...
Giovanni Lasagni,Laura Vetrugno,Chiara Maria Maggiore et al. Giovanni Lasagni et al.
Background: Food allergy is a growing public health concern, and oral immunotherapy (OIT) has emerged as a promising approach to induce desensitization and potentially sustained unresponsiveness to allergenic foods. Chang...
Hannah Victoria Giles,Bhuvan Kishore Hannah Victoria Giles
Bispecific antibodies (BsAbs) have emerged as an important new class drugs for the treatment of multiple myeloma (MM) over the last few years. Currently, BsAbs are only licensed for use as monotherapy in patients with relapsed/refractory MM...
Kinsley Wang,Kyle Taing,Robert Hsu Kinsley Wang
Background/Objectives: Small-cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy characterized by rapid proliferation, early metastasis, and near-universal relapse after initial therapy. While chemo-immunotherapy modestly imp...
Anna Balata,Katarzyna Pogoda Anna Balata
Breast cancer remains the most common malignancy and one of the leading causes of cancer-related death among women worldwide. Advances in antibody-based therapies have improved outcomes across all biological subtypes: HER2-positive, triple-...
Alexandra Rak,Yana Zabrodskaya,Pei-Fong Wong et al. Alexandra Rak et al.
Background/objectives: Notwithstanding the declaration by the World Health Organization in May 2023 regarding the conclusion of the COVID-19 pandemic, new cases of this potentially lethal infection continue to be document...
Deepika Godugu,Kranthi Gattu,Parul Suri et al. Deepika Godugu et al.
Nanobodies (single-domain antibodies, VHHs) have emerged as versatile tools for evaluating and treating Alzheimer's disease (AD). They offer distinct engineering benefits compared with traditional antibodies and small molecules, including s...
Jung Gu Lee,Inseo Lee,Joo-Young Kim et al. Jung Gu Lee et al.
Background: The Fc region of immunoglobulin G (IgG) is a key target in therapeutic and analytical applications, such as antibody purification and site-specific bioconjugation. Although Protein A exhibits strong Fc-binding...